Dashboard
Financial statements
CRL

Company financials

Charles River Laboratories

Health Care Life Sciences Tools & Services Wilmington, Massachusetts Last filing Feb 18, 2026 · FY2025
Revenue FY2025
$4.0B
Net income FY2025
$-144.3M
Total assets FY2024
$7.5B
Operating cash flow FY2024
$22.2M

Balance Sheet

Assets, liabilities, and equity

14 accounts · 5 years
Total assets $7.5B
Total liabilities $4.0B
Shareholders equity $3.5B
Account 2025 2024 2023 2022 2021
Statement
BS Assets Cash $0 $233.9M
BS Assets Accts Receivable $0 $752.4M
BS Assets Inventory $0 $255.8M
BS Assets Prepaid Expenses $0 $107.6M
BS Assets PPE $0 $1.5B
BS Assets Goodwill $0 $2.8B
BS Assets Intangible Assets $0 $955.3M
BS Assets Other Noncurrent $0 $148.3M
BS Liab Accrued Liab $0 $219.8M
BS Liab Other Noncurrent $0 $174.8M
BS Equity Preferred Stock $0 $0
BS Equity Common Stock $0 $509.0K
BS Equity Treasury Stock $360.1M $0
BS Equity AOCI $0 $-262.1M